Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1012299

registered interest
date	22/11/2018
answering body	Department for Education
answering dept id	60
answering dept short name	Education
answering dept sort name	Education
hansard heading	Teachers: Pay
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Education, whether he plans to allocate new moneys to fund in full the pay award for teaching staff in Catholic sixth-form colleges; and if he will make a statement.
tabling member constituency	Harrow West
tabling member printed	Gareth Thomas
uin	194581
answer	answer is ministerial correction date of answer 30/11/2018 answer text <p>Further education (FE) providers, including Catholic sixth-form colleges, are independent institutions responsible for setting their own staff salaries, and the government has no current plans to allocate money to assist with any increases in their teachers’ pay.</p><p>However, we know that FE faces cost pressures, and we are working with the sector to look closely at funding, to see what more we can do and to inform Spending Review planning.</p> answering member constituency Guildford answering member printed Anne Milton question first answered 30/11/2018 11:30:05 answering member 1523 label Biography information for Anne Milton
tabling member	177 label Biography information for Gareth Thomas

1007881

registered interest
date	15/11/2018
answering body	Ministry of Defence
answering dept id	11
answering dept short name	Defence
answering dept sort name	Defence
hansard heading	Armed Forces: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Defence, what estimate he has made of the cost to the public purse of his Department's spend on each of the following pharmaceuticals for service personnel (a) Cerezyme Infusion 400u VL, (b) Chenodeoxycholic Acid Capsules 250mg, (c) Orfadin Capsules 10mg, (d) Kalydeco Tablets 150mg, (e) Sovaldi Tablets 400mg, (f) Trientine Dihydroch Capsules 300mg, (g) Glivec Tablets 400mg, (h) Imatinib Tablets Mesil tablets 400mg, (I) Glivec Tablets 100mg and (j) Stelara Injection 45mg/0.5ml.
tabling member constituency	Harrow West
tabling member printed	Gareth Thomas
uin	191853
answer	answer is ministerial correction date of answer 22/11/2018 answer text <p>During the last four financial years (2014-15 to 2017-18) the Ministry of Defence purchased Glivec Tablets 400mg and Stelara Injection 45mg/0.5ml at a cost of £3,208 and £2,147 respectively.</p> answering member constituency Pudsey answering member printed Stuart Andrew question first answered 22/11/2018 14:57:26 answering member 4032 label Biography information for Stuart Andrew
tabling member	177 label Biography information for Gareth Thomas

1000233

registered interest
date	02/11/2018
answering body	Treasury
answering dept id	14
answering dept short name	Treasury
answering dept sort name	Treasury
hansard heading	Locums: Tax Avoidance
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Chancellor of the Exchequer, what estimate his Department has made of the effect on locum doctors and nurses of the 2019 loan charge for disguised remuneration schemes.
tabling member constituency	Harrow West
tabling member printed	Gareth Thomas
uin	187296
answer	answer is ministerial correction date of answer 12/11/2018 answer text <p>I refer the Honourable member to my statement made on 5<sup>th</sup> November 2018, to Parliamentary Question 186276:</p><p><a href="https://www.parliament.uk/business/publications/written-questions-answers-statements/written-question/Commons/2018-10-31/186276/" target="_blank">https://www.parliament.uk/business/publications/written-questions-answers-statements/written-question/Commons/2018-10-31/186276/</a></p> answering member constituency Central Devon answering member printed Mel Stride question first answered 12/11/2018 10:27:47 answering member 3935 label Biography information for Mel Stride
tabling member	177 label Biography information for Gareth Thomas

999385

registered interest
date	31/10/2018
answering body	Department for Business, Energy and Industrial Strategy
answering dept id	201
answering dept short name	Business, Energy and Industrial Strategy
answering dept sort name	Business, Energy and Industrial Strategy
hansard heading	Drugs: Prices
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Business, Energy and Industrial Strategy, what assessment he has made of the effectiveness of the Intellectual Property Office in helping to keep new drug prices at affordable levels; and if he will make a statement.
tabling member constituency	Harrow West
tabling member printed	Gareth Thomas
uin	186161
answer	answer is ministerial correction date of answer 05/11/2018 answer text <p>This Government is committed to ensuring patients have access to the medicines they need and that they are cost-effective and affordable to the NHS.</p><p> </p><p>The Intellectual Property Office has no role in the negotiating and setting of drug prices which is the responsibility of the Department for Health and Social Care.</p> answering member constituency East Surrey answering member printed Mr Sam Gyimah question first answered 05/11/2018 16:30:30 answering member 3980 label Biography information for Mr Sam Gyimah
tabling member	177 label Biography information for Gareth Thomas

999387

registered interest
date	31/10/2018
answering body	Ministry of Defence
answering dept id	11
answering dept short name	Defence
answering dept sort name	Defence
hansard heading	Ministry of Defence: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Defence, if she will publish the top 10 drugs by purchased by his Department in each of the last five years; and if he will make a statement.
tabling member constituency	Harrow West
tabling member printed	Gareth Thomas
uin	186162
answer	answer is ministerial correction date of answer 05/11/2018 answer text <p>The top 10 drugs purchased by the Ministry of Defence in each of the last five years by value is as follows:</p><p> </p><p><strong>2017-18</strong></p><table><tbody><tr><td><p><strong>Description</strong></p></td></tr><tr><td><p>RABIES VACCINE BP SINGLE DOSE VIAL WITH DILUENT WATER FOR INJ 1ML SYRINGE (RAB/VAC) 1 X PK 'RABIPUR'</p></td></tr><tr><td><p>PROGUANIL HYDROCHLORIDE 100MG ATOVAQUONE 250MG F/C TABLETS 1 X 12 PACK</p></td></tr><tr><td><p>MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUPS A,C,Y AND W-135 COMBINED <br> POWDER AND SOLUTION FOR INJECTION INTRAMUSCULAR USE 1 X VIAL WITH 1 X VIAL DILUENT 'MENVEO'</p></td></tr><tr><td><p>YELLOW FEVER VACCINE (LIVE) SINGLE DOSE VIAL POWDER FOR INJECTION WITH <br> 0.5ML NACL INJECTION IN SYRINGE 1 X PACK 'STAMARIL'</p></td></tr><tr><td><p>OVER-LABELLED - 12 PROGUANIL/ATOVAQUONE 100/250mg TABLETS-GENERIC</p></td></tr><tr><td><p>ENCEPHALITIS TICK-BORNE VACCINE INACTIVATED 1 X 0.5ML PRELOADED SYRINGE</p></td></tr><tr><td><p>TYPHOID VACCINE POLYSACCARIDE 50MCG/ML SINGLE DOSE 0.5ML PREFILLED <br> SYRINGE 1 X 10 PACK</p></td></tr><tr><td><p>ADALIMUMAB 40MG SOLUTION FOR INJECTION IN 0.4ML PRE-FILLED PEN PACK OF <br> 2 PENS 'HUMIRA'</p></td></tr><tr><td><p>DIPHTHERIA, TETANUS AND PERTUSSIS TOXOID (ACELLULAR) AND HEPATITIS B, <br> POLIOVIRUS AND HAEMOPHILUS TYPE B (HIB) VACCINE PRE-FILLED SYRINGE '<br> INFANRIX HEXA'</p></td></tr><tr><td><p>RABIES VACCINE BP POWDER AND SOLVENT FOR SUSPENSION FOR INJECTION <br> PACK OF 1 VIAL AND 1 PREFILLED SYRINGE 'RABIES BP'</p></td></tr></tbody></table><p> </p><p> </p><p><strong>2016-17</strong></p><table><tbody><tr><td><p><strong>Description</strong></p></td></tr><tr><td><p>PROGUANIL HYDROCHLORIDE 100MG ATOVAQUONE 250MG F/C TABLETS 1 X 12 PACK</p></td></tr><tr><td><p>MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUPS A,C,Y AND W-135 COMBINED POWDER AND SOLUTION FOR INJECTION INTRAMUSCULAR USE 1 X VIAL WITH 1 X VIAL DILUENT 'MENVEO'</p></td></tr><tr><td><p>ENCEPHALITIS TICK-BORNE VACCINE INACTIVATED 1 X 0.5ML PRELOADED SYRINGE</p></td></tr><tr><td><p>YELLOW FEVER VACCINE (LIVE) SINGLE DOSE VIAL POWDER FOR INJECTION WITH 0.5ML NACL INJECTION IN SYRINGE 1 X PACK 'STAMARIL'</p></td></tr><tr><td><p>RABIES VACCINE BP SINGLE DOSE VIAL WITH DILUENT WATER FOR INJ 1ML SYRINGE (RAB/VAC) 1 X PK 'RABIPUR'</p></td></tr><tr><td><p>HEPATITIS B RECOMBINANT VACCINE ADSORBED 'ENGERIX' 20MCG/ML SUSPENSION FOR INJECTION 1ML PRE-FILLED SYRINGE PACK OF 10</p></td></tr><tr><td><p>ETANERCEPT 50MG PRE-FILLED PEN PACK OF 4</p></td></tr><tr><td><p>FENTANYL CITRATE;LOZENGE;800mcg;LOZENGE w/INTEGRAL OROMUCOSAL APPLICATOR; 1x3</p></td></tr><tr><td><p>HEPATITIS A VIRUS VACCINE INACTIVATED 1ML PFS PACK OF 10 'HAVRIX'</p></td></tr><tr><td><p>PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE (13-VALENT ADSORBED) SUSP FOR INJ IN 0.5ML PRE-FILLED SYRINGE PK OF 10 'PREVENAR 13'</p></td></tr></tbody></table><p> </p><p><strong>2015-16</strong></p><table><tbody><tr><td><p><strong>Description</strong></p></td></tr><tr><td><p>YELLOW FEVER VACCINE (LIVE) SINGLE DOSE VIAL POWDER FOR INJECTION WITH 0.5ML NACL INJECTION IN SYRINGE 1 X PACK 'STAMARIL'</p></td></tr><tr><td><p>HEPATITIS B RECOMBINANT VACCINE ADSORBED 'ENGERIX' 20MCG/ML SUSPENSION FOR INJECTION 1ML PRE-FILLED SYRINGE PACK OF 10</p></td></tr><tr><td><p>MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUPS A,C,Y AND W-135 COMBINED POWDER AND SOLUTION FOR INJECTION INTRAMUSCULAR USE 1 X VIAL WITH 1 X VIAL DILUENT 'MENVEO'</p></td></tr><tr><td><p>PROGUANIL HYDROCHLORIDE 100MG ATOVAQUONE 250MG F/C TABLETS 1 X 12 PACK</p></td></tr><tr><td><p>RABIES VACCINE BP SINGLE DOSE VIAL WITH DILUENT WATER FOR INJ 1ML SYRINGE (RAB/VAC) 1 X PK 'RABIPUR'</p></td></tr><tr><td><p>TYPHOID VACCINE POLYSACCARIDE 50MCG/ML SINGLE DOSE 0.5ML PREFILLED SYRINGE 1 X 10 PACK</p></td></tr><tr><td><p>FENTANYL CITRATE;LOZENGE;800mcg;LOZENGE w/INTEGRAL OROMUCOSAL APPLICATOR; 1x3</p></td></tr><tr><td><p>JAPANESE ENCEPHALITIS VACCINE (INACTIVATED, ADSORBED) SUSPENSION FOR INJECTION IN 0.5ML PRE-FILLED SYRINGE IXIARO</p></td></tr><tr><td><p>ETANERCEPT 50MG PRE-FILLED PEN PACK OF 4</p></td></tr><tr><td><p>ENCEPHALITIS TICK-BORNE VACCINE INACTIVATED 1 X 0.5ML PRELOADED SYRINGE</p></td></tr></tbody></table><p> </p><p><strong>2014-15</strong></p><table><tbody><tr><td><p><strong>Description</strong></p></td></tr><tr><td><p>PROGUANIL HYDROCHLORIDE 100MG ATOVAQUONE 250MG F/C TABLETS 1 X 12 PACK</p></td></tr><tr><td><p>YELLOW FEVER VACCINE (LIVE) SINGLE DOSE VIAL POWDER FOR INJECTION WITH 0.5ML NACL INJECTION IN SYRINGE 1 X PACK 'STAMARIL'</p></td></tr><tr><td><p>HEPATITIS B RECOMBINANT VACCINE ADSORBED 'ENGERIX' 20MCG/ML SUSPENSION FOR INJECTION 1ML PRE-FILLED SYRINGE PACK OF 10</p></td></tr><tr><td><p>YELLOW FEVER VACCINE 'STAMARIL' (LIVE) UNLICENSED 10 DOSE VIAL PACK OF 10 VIALS (100 DOSE TOTAL)</p></td></tr><tr><td><p>MEFLOQUINE HYDROCHLORIDE 250MG TABLET 1 X 8 PACK</p></td></tr><tr><td><p>RABIES VACCINE BP SINGLE DOSE VIAL WITH DILUENT WATER FOR INJ 1ML SYRINGE (RAB/VAC) 1 X PK 'RABIPUR'</p></td></tr><tr><td><p>MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUPS A,C,Y AND W-135 COMBINED POWDER AND SOLUTION FOR INJECTION INTRAMUSCULAR USE 1 X VIAL WITH 1 X VIAL DILUENT 'MENVEO'</p></td></tr><tr><td><p>PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE (13-VALENT ADSORBED) SUSP FOR INJ IN 0.5ML PRE-FILLED SYRINGE PK OF 10 'PREVENAR 13'</p></td></tr><tr><td><p>HEPATITIS A VIRUS VACCINE INACTIVATED 1ML PFS PACK OF 10 'HAVRIX'</p></td></tr><tr><td><p>JAPANESE ENCEPHALITIS VACCINE (INACTIVATED, ADSORBED) SUSPENSION FOR INJECTION IN 0.5ML PRE-FILLED SYRINGE IXIARO</p></td></tr></tbody></table><p> </p><p><strong>2013-14</strong></p><table><tbody><tr><td><p><strong>Description</strong></p></td></tr><tr><td><p>YELLOW FEVER VACCINE (LIVE) SINGLE DOSE VIAL POWDER FOR INJECTION WITH 0.5ML NACL INJECTION IN SYRINGE 1 X PACK 'STAMARIL'</p></td></tr><tr><td><p>HEPATITIS B RECOMBINANT VACCINE ADSORBED 'ENGERIX' 20MCG/ML SUSPENSION FOR INJECTION 1ML PRE-FILLED SYRINGE PACK OF 10</p></td></tr><tr><td><p>PROGUANIL HYDROCHLORIDE 100MG ATOVAQUONE 250MG F/C TABLETS 1 X 12 PACK</p></td></tr><tr><td><p>PROGUANIL HYDROCHLORIDE 100MG TABLETS X 98 AND CHLOROQUINE PHOSPHATE 250MG TABLETS X 14 1 X 112 TABLET TRAVEL PACK</p></td></tr><tr><td><p>MEFLOQUINE HYDROCHLORIDE 250MG TABLET 1 X 8 PACK</p></td></tr><tr><td><p>HEPATITIS A&amp;B VACCINE 'TWINRIX'</p></td></tr><tr><td><p>HEPATITIS B VACCINE 20MCG/ML ADSORBED 1 X 1ML PRE-FILLED SYRINGE</p></td></tr><tr><td><p>HEPATITIS A VACCINE INACTIVATED 1 X PREFILLED SYRINGE</p></td></tr><tr><td><p>MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUPS A,C,Y AND W-135 COMBINED POWDER AND SOLUTION FOR INJECTION INTRAMUSCULAR USE 1 X VIAL WITH 1 X VIAL DILUENT 'MENVEO'</p></td></tr><tr><td><p>YELLOW FEVER VACCINE 'STAMARIL' (LIVE) UNLICENSED 10 DOSE VIAL PACK OF 10 VIALS (100 DOSE TOTAL)</p></td></tr></tbody></table><p> </p><p> </p><p> </p><p> </p> answering member constituency Bournemouth East answering member printed Mr Tobias Ellwood question first answered 05/11/2018 17:04:24 answering member 1487 label Biography information for Mr Tobias Ellwood
tabling member	177 label Biography information for Gareth Thomas

999389

registered interest
date	31/10/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Harvoni
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to reduce the cost to the NHS of Harvoni; and if he will make a statement.
tabling member constituency	Harrow West
tabling member printed	Gareth Thomas
uin	186163
answer	answer is ministerial correction date of answer 05/11/2018 answer text <p>We are informed by NHS England that in order to ensure the best use of public funds, the National Health Service has used the procurement process to ensure that optimal value for money is achieved when purchasing drugs, which are used in secondary care.</p><p> </p><p>The NHS is working to ensure consistent use of clinically-appropriate lowest acquisition cost drugs. This has encouraged competitive pricing in return for market share. This process has allowed for an increase in the number of patients being cured within the available resources, with in excess of 30,000 patients with hepatitis C treated so far. The NHS is currently undertaking a long-term strategic procurement to increase treatment and improve value further.</p><p> </p><p>NHS England’s Commercial Medicines Unit’s six-monthly tenders, together with innovative approaches which mean the NHS is given a refund if a course of treatment does not result in cure, have succeeded in delivering reduced price per patient for all direct acting antiviral Hepatitis C drugs, such as Harvoni (ledipasvir-sofosbuvir).</p><p> </p><p>The Department has made no such estimate of the number of patients recommended the drug Harvoni by medical practitioners who have been denied access on the grounds of affordability.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 186164 question first answered 05/11/2018 15:34:31 answering member 4067 label Biography information for Steve Brine
tabling member	177 label Biography information for Gareth Thomas

999392

registered interest
date	31/10/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Harvoni
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what estimate he has made of the number of patients recommended the drug Harvoni by medical practitioners who have been denied access to the drug on grounds of affordability; and if he will make a statement.
tabling member constituency	Harrow West
tabling member printed	Gareth Thomas
uin	186164
answer	answer is ministerial correction date of answer 05/11/2018 answer text <p>We are informed by NHS England that in order to ensure the best use of public funds, the National Health Service has used the procurement process to ensure that optimal value for money is achieved when purchasing drugs, which are used in secondary care.</p><p> </p><p>The NHS is working to ensure consistent use of clinically-appropriate lowest acquisition cost drugs. This has encouraged competitive pricing in return for market share. This process has allowed for an increase in the number of patients being cured within the available resources, with in excess of 30,000 patients with hepatitis C treated so far. The NHS is currently undertaking a long-term strategic procurement to increase treatment and improve value further.</p><p> </p><p>NHS England’s Commercial Medicines Unit’s six-monthly tenders, together with innovative approaches which mean the NHS is given a refund if a course of treatment does not result in cure, have succeeded in delivering reduced price per patient for all direct acting antiviral Hepatitis C drugs, such as Harvoni (ledipasvir-sofosbuvir).</p><p> </p><p>The Department has made no such estimate of the number of patients recommended the drug Harvoni by medical practitioners who have been denied access on the grounds of affordability.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 186163 question first answered 05/11/2018 15:34:31 answering member 4067 label Biography information for Steve Brine
tabling member	177 label Biography information for Gareth Thomas

997492

registered interest
date	30/10/2018
answering body	Foreign and Commonwealth Office
answering dept id	16
answering dept short name	Foreign and Commonwealth Office
answering dept sort name	Foreign and Commonwealth Office
hansard heading	Sri Lanka: Human Rights
house id	1
legislature	25259 pref label House of Commons
question text	What recent steps he has taken to promote human rights in Sri Lanka.
tabling member constituency	Harrow West
tabling member printed	Gareth Thomas
uin	907365
answer	answer is ministerial correction date of answer 30/10/2018 answer text <p>I am concerned by the developing political situation in Sri Lanka. I have called on all parties to ensure that the constitution is respected and due political and legal process upheld. The UK urges the President, in consultation with the Speaker, to reconvene parliament immediately to give the democratically elected representatives of the Sri Lankan people their voice. We shall also continue to urge Sri Lanka to implement fully the commitments it has willingly made to the UN Human Rights Council.</p> answering member constituency Cities of London and Westminster answering member printed Mark Field question first answered 30/10/2018 16:45:53 answering member 1405 label Biography information for Mark Field
tabling member	177 label Biography information for Gareth Thomas

984779

registered interest
date	10/10/2018
answering body	Department for Business, Energy and Industrial Strategy
answering dept id	201
answering dept short name	Business, Energy and Industrial Strategy
answering dept sort name	Business, Energy and Industrial Strategy
hansard heading	Post Offices
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Business, Energy and Industrial Strategy, what discussions his Department has had with representatives of the Post Office on ensuring the size and accessibility of the branch network.
tabling member constituency	Harrow West
tabling member printed	Gareth Thomas
uin	177571
answer	answer is ministerial correction date of answer 23/10/2018 answer text <p>In our 2017 Manifesto we committed to safeguarding a Post Office network of at least 11,500 branches and to protect existing rural services. The Government sets the parameters in which the Post Office operates and then allows the Post Office to operate as an independent commercial organisation.</p><p>BEIS officials are in regular discussions with the Post Office and continue to monitor the network size.</p> answering member constituency Rochester and Strood answering member printed Kelly Tolhurst question first answered 23/10/2018 14:30:13 answering member 4487 label Biography information for Kelly Tolhurst
tabling member	177 label Biography information for Gareth Thomas

983253

registered interest
date	08/10/2018
answering body	Treasury
answering dept id	14
answering dept short name	Treasury
answering dept sort name	Treasury
hansard heading	Mutual Societies: Australia
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Chancellor of the Exchequer, whether he has had discussions with his Australian counterpart on the Australian Government's proposed Treasury Laws Amendment (Mutual Entities) Bill; and if he will make a statement.
tabling member constituency	Harrow West
tabling member printed	Gareth Thomas
uin	175840
answer	answer is ministerial correction date of answer 16/10/2018 answer text <p>HM Treasury has had no discussions with the Australian Government on the proposed Treasury Laws Amendment (Mutual Entities) Bill.</p><p> </p><p>The Government remains committed to supporting co-operatives, credit unions, building societies and other mutual legal forms as part of a diverse and resilient economy which offers choice to consumers.</p><p> </p> answering member constituency Salisbury answering member printed John Glen question first answered 16/10/2018 16:03:11 answering member 4051 label Biography information for John Glen
tabling member	177 label Biography information for Gareth Thomas